Steven Lavelle Baker, APSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 1238 Pleasant Valley Dr, Hobart, WI 54155 Phone: 920-784-9276 |
News Archive
Trius Therapeutics, Inc., a biopharmaceutical company developing innovative antibiotics for serious, life-threatening infections, announced today the initial public offering of 10,000,000 shares of its common stock at a price of $5.00 per share. The common stock is expected to begin trading on the NASDAQ Global Market on August 3, 2010 under the trading symbol "TSRX." Trius has granted the underwriters a 45 day option to purchase up to 750,000 shares of its common stock at the initial public offering price to cover over-allotments, if any.
Henry Ford Cancer Institute has treated its first patient with CAR T-cell therapy, an approach that uses engineered cells from a patient's immune system to destroy cancer.
FRC Action PAC, the political action committee connected to Family Research Council Action, praised Alaska's voters for affirming the right of parents to be notified should their minor daughter seek an abortion. The measure passed by a 55-45 percent margin.
A first-of-its-kind contraceptive developed at the University of Illinois Chicago has been approved by the U.S. Food and Drug Administration.
› Verified 3 days ago